CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Total Edwards Lifesciences Corporation Stockholders' Equity	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2023			650.5
Beginning balance at Dec. 31, 2023	$ 6,719.4	$ 6,650.0	$ 650.5	$ (5,024.5)	$ 2,274.4	$ 8,992.4	$ (242.8)	$ 69.4
Treasury stock, beginning balance (in shares) at Dec. 31, 2023				49.4
Increase (Decrease) in Stockholders' Equity
Net income	351.0	351.9				351.9		(0.9)
Other comprehensive (loss) gain, net of tax	9.5	9.5					9.5
Common stock issued under stock plans and other (in shares)			1.3
Common stock issued under stock plans and other	62.1	62.1	$ 1.3		60.8
Stock-based compensation expense	44.6	44.6			44.6
Purchases of treasury stock	(0.2)	(0.2)		$ (0.2)
Common stock, ending balance (in shares) at Mar. 31, 2024			651.8
Ending balance at Mar. 31, 2024	7,186.4	7,117.9	$ 651.8	$ (5,024.7)	2,379.8	9,344.3	(233.3)	68.5
Treasury stock, ending balance (in shares) at Mar. 31, 2024				49.4
Common stock, beginning balance (in shares) at Dec. 31, 2023			650.5
Beginning balance at Dec. 31, 2023	6,719.4	6,650.0	$ 650.5	$ (5,024.5)	2,274.4	8,992.4	(242.8)	69.4
Treasury stock, beginning balance (in shares) at Dec. 31, 2023				49.4
Increase (Decrease) in Stockholders' Equity
Net income	716.0
Common stock, ending balance (in shares) at Jun. 30, 2024			653.5
Ending balance at Jun. 30, 2024	7,504.6	7,437.4	$ 653.5	$ (5,182.8)	2,476.3	9,710.6	(220.2)	67.2
Treasury stock, ending balance (in shares) at Jun. 30, 2024				51.2
Common stock, beginning balance (in shares) at Mar. 31, 2024			651.8
Beginning balance at Mar. 31, 2024	7,186.4	7,117.9	$ 651.8	$ (5,024.7)	2,379.8	9,344.3	(233.3)	68.5
Treasury stock, beginning balance (in shares) at Mar. 31, 2024				49.4
Increase (Decrease) in Stockholders' Equity
Net income	365.0	366.3				366.3		(1.3)
Other comprehensive (loss) gain, net of tax	13.1	13.1					13.1
Common stock issued under stock plans and other (in shares)			1.7
Common stock issued under stock plans and other	54.3	54.3	$ 1.7		52.6
Stock-based compensation expense	43.9	43.9			43.9
Purchases of treasury stock (in shares)				1.8
Purchases of treasury stock	(158.1)	(158.1)		$ (158.1)
Common stock, ending balance (in shares) at Jun. 30, 2024			653.5
Ending balance at Jun. 30, 2024	$ 7,504.6	7,437.4	$ 653.5	$ (5,182.8)	2,476.3	9,710.6	(220.2)	67.2
Treasury stock, ending balance (in shares) at Jun. 30, 2024				51.2
Common stock, beginning balance (in shares) at Dec. 31, 2024	588.6		654.8
Beginning balance at Dec. 31, 2024	$ 10,062.9	9,998.4	$ 654.8	$ (6,192.3)	2,613.4	13,167.0	(244.5)	64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024	66.2			66.2
Increase (Decrease) in Stockholders' Equity
Net income	$ 356.4	358.0				358.0		(1.6)
Other comprehensive (loss) gain, net of tax	(10.0)	(10.0)					(10.0)
Common stock issued under stock plans and other (in shares)			1.1
Common stock issued under stock plans and other	50.7	50.7	$ 1.1		49.6
Stock-based compensation expense	40.2	40.2			40.2
Purchases of treasury stock (in shares)				3.5
Purchases of treasury stock	(308.6)	(308.6)		$ (258.6)	(50.0)
Common stock, ending balance (in shares) at Mar. 31, 2025			655.9
Ending balance at Mar. 31, 2025	$ 10,191.6	10,128.7	$ 655.9	$ (6,450.9)	2,653.2	13,525.0	(254.5)	62.9
Treasury stock, ending balance (in shares) at Mar. 31, 2025				69.7
Common stock, beginning balance (in shares) at Dec. 31, 2024	588.6		654.8
Beginning balance at Dec. 31, 2024	$ 10,062.9	9,998.4	$ 654.8	$ (6,192.3)	2,613.4	13,167.0	(244.5)	64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024	66.2			66.2
Increase (Decrease) in Stockholders' Equity
Net income	$ 687.9
Common stock, ending balance (in shares) at Jun. 30, 2025	587.9		657.6
Ending balance at Jun. 30, 2025	$ 10,606.5	10,545.3	$ 657.6	$ (6,456.4)	2,750.0	13,858.2	(264.1)	61.2
Treasury stock, ending balance (in shares) at Jun. 30, 2025	69.7			69.7
Common stock, beginning balance (in shares) at Mar. 31, 2025			655.9
Beginning balance at Mar. 31, 2025	$ 10,191.6	10,128.7	$ 655.9	$ (6,450.9)	2,653.2	13,525.0	(254.5)	62.9
Treasury stock, beginning balance (in shares) at Mar. 31, 2025				69.7
Increase (Decrease) in Stockholders' Equity
Net income	331.5	333.2				333.2		(1.7)
Other comprehensive (loss) gain, net of tax	(9.6)	(9.6)					(9.6)
Common stock issued under stock plans and other (in shares)			1.7
Common stock issued under stock plans and other	61.0	61.0	$ 1.7		59.3
Stock-based compensation expense	37.5	37.5			37.5
Purchases of treasury stock	$ (5.5)	(5.5)		$ (5.5)
Common stock, ending balance (in shares) at Jun. 30, 2025	587.9		657.6
Ending balance at Jun. 30, 2025	$ 10,606.5	$ 10,545.3	$ 657.6	$ (6,456.4)	$ 2,750.0	$ 13,858.2	$ (264.1)	$ 61.2
Treasury stock, ending balance (in shares) at Jun. 30, 2025	69.7			69.7